High throughput targeted gene sequencing in 738 Myelodysplastic Syndromes patients reveals novel oncogenic genes, rare driver mutations and complex molecular signatures with potential impact for patient diagnosis and prognosis in the clinic

Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem, Peter Van Loo, Andrea Pellagatti, Michael J. Groves, Nick C. P. Cross, Carlo Gambacorti-Passerini, Anthony R. Green, Jacqueline Boultwood, Paresh Vyas, Eva Hellstrom-Lindberg, David Bowen, Mario Cazzola, Michael R. Stratton, Peter Campbell

Research output: Contribution to journalMeeting abstractpeer-review

Cite this